JPMorgan Chase & Co. Increases Molina Healthcare Price Target to $39.00 (MOH)
Analysts at JPMorgan Chase & Co. hoisted their price target on shares of Molina Healthcare (NYSE:MOH) from $29.00 to $39.00 in a research report issued to clients and investors on Sunday, AnalystRatings.Net reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.’s price objective would suggest a potential upside of 6.44% from the stock’s previous close.
Shares of Molina Healthcare (NYSE:MOH) opened at 36.64 on Friday. Molina Healthcare has a 1-year low of $21.74 and a 1-year high of $40.90. The stock’s 50-day moving average is $35.83 and its 200-day moving average is $35.64. The company has a market cap of $1.674 billion and a P/E ratio of 20.57.
Molina Healthcare (NYSE:MOH) last released its earnings data on Thursday, July 25th. The company reported $0.34 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.31 by $0.03. The company had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.61 billion. During the same quarter in the prior year, the company posted ($0.80) earnings per share. The company’s quarterly revenue was up 8.6% on a year-over-year basis. Analysts expect that Molina Healthcare will post $1.61 EPS for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at Jefferies Group upgraded shares of Molina Healthcare (NYSE:MOH) from a “hold” rating to a “buy” rating in a research note to investors on Monday, September 16th. They now have a $47.00 price target on the stock, up previously from $36.00. Separately, analysts at TheStreet downgraded shares of Molina Healthcare (NYSE:MOH) from a “buy” rating to a “hold” rating in a research note to investors on Thursday, September 12th. Finally, analysts at Susquehanna raised their price target on shares of Molina Healthcare (NYSE:MOH) from $45.00 to $46.00 in a research note to investors on Friday, July 26th. They now have a “positive” rating on the stock.
Six research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Molina Healthcare presently has a consensus rating of “Hold” and a consensus price target of $40.80.
In other Molina Healthcare news, Director Charles Z. Fedak sold 2,500 shares of the company’s stock on the open market in a transaction dated Wednesday, September 11th. The stock was sold at an average price of $36.90, for a total value of $92,250.00. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Molina Healthcare, Inc provides medicaid-related solutions. The Company operates in two segments: Health Plans and Molina Medicaid Solutions.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.